Tirzepatide is a cutting-edge dual GIP/GLP-1 receptor agonist. This medication has shown exceptional results in clinical trials for the treatment of type 2 diabetes. By activating both the GIP and GLP-1 receptors, https://mariyahihff821201.blogdigy.com/tirzepatide-a-promising-novel-agent-for-diabetes-64756224